Breast Breaking News

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer

Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial

Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery

A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients

Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy

Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer

The impact of radiotherapy on trials of axillary management in early breastcancer